4//SEC Filing
Yu Yong 4
Accession 0001493152-25-027338
CIK 0001231457other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 8:50 PM ET
Size
6.8 KB
Accession
0001493152-25-027338
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Yu Yong
VP, Clinical Trial Operations
Transactions
- Sale
Common Stock
2025-08-21$3.36/sh−3,219$10,807→ 146,817 total - Sale
Common Stock
2025-11-17$5.37/sh−973$5,224→ 145,844 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.
- [F2]The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025.
Documents
Issuer
GENELUX Corp
CIK 0001231457
Entity typeother
Related Parties
1- filerCIK 0001937482
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 8:50 PM ET
- Size
- 6.8 KB